cafergot discontinued No Further a Mystery
ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) will increase the stage or outcome of ergotamine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Acute ergot toxicity characterised by vasospasm and tissue ischemia is connected with coadministration of ritonavirBecause CYP3A4 inhibition elevates ergotamine and caffeine